JoelMLamonMD

PubMed

• Our patient pulled a fast one on Medicare--and on us.
  Joel Lamon> ;Medical Economics. 2000 Aug 7
• 1 citations
  Cancer surveillance. Who stands to benefit
  Joel M. Lamon> ;Postgraduate Medicine. 1985 Sep 1
• 15 citations
  Neurotoxic aspects of porphyrinopathies: lead and succinylacetone.
  Ellen K. Silbergeld, Robert E. Hruska, Diane Bradley, Joel M. Lamon, Bruce C. Frykholm> ;Environmental Research. 1982 Dec 1
• Letters to the EditorIRON CHELATION IN RED CELL GHOSTS
  GeraldN. Smith, Ralph Green, Joel Lamon, Deborah Curran> ;Lancet. 1980 Dec 27
• 26 citations
  Role of altered heme synthesis in lead neurotoxicity.
  Ellen K. Silbergeld, Joel M. Lamon> ;Journal of Occupational Medicine.. 1980 Oct 1
• 27 citations
  Clinical trial of desferrioxamine entrapped in red cell ghosts.
  Ralph Green, Joel Lamon, Deborah Curran> ;Lancet. 1980 Aug 16
• 52 citations
  Hepatic protoporphyrin production in human protoporphyria: Effects of intravenous hematin and analysis of erythrocyte protoporphyrin distribution
  Joel M. Lamon, Maureen B. Poh-Fitzpatrick, Angelo A. Lamola> ;Gastroenterology. 1980 Jul 1
• 77 citations
  Hematin therapy for acute porphyria.
  Joel M. Lamon, Bruce C. Frykholm, Richard A. Hess, Donald P. Tschudy> ;Medicine. 1979 May 1
• 12 citations
  Hematin administration to an adult with lead intoxication
  Joel M. Lamon, Bruce C. Frykholm, Donald P. Tschudy> ;Blood. 1979 May 1
• 65 citations
  Idiopathic hemochromatosis in a young female. A case study and review of the syndrome in young people
  Joel M. Lamon, Samuel P. Marynick, Randall Rosenblatt, Sheila Donnelly> ;Gastroenterology. 1979 Jan 1
• 17 citations
  Danazol Administration to Females with Menses-Associated Exacerbations of Acute Intermittent Porphyria
  Joel M. Lamon, Bruce C. Frykholm, William Herrera, Donald P. Tschudy> ;The Journal of Clinical Endocrinology and Metabolism. 1979 Jan 1
• 38 citations
  PREVENTION OF ACUTE PORPHYRIC ATTACKS BY INTRAVENOUS HÆMATIN
  JoelM. Lamon, BruceC. Frykholm, Melvina Bennett, DonaldP. Tschudy> ;Lancet. 1978 Sep 2
• 2 citations
  Tyrosinemia with aminolevulinicdehydratase deficiency
  Joel M. Lamon, Bruce C. Frykholm, Donald P. Tschudy> ;The Journal of Pediatrics. 1978 Feb 1
• 8 citations
  Screening Tests in Acute Porphyria
  Joel M. Lamon, Bruce C. Frykholm, Donald P. Tschudy> ;Archives of Neurology. 1977 Nov 1
• 29 citations
  The Hoesch Test: Bedside Screening for Urinary Porphobilinogen in Patients with Suspected Porphyria
  Joel Lamon, Allan G. Redeker> ;Clinical Chemistry. 1974 Nov 1
• TLC of porphyrins.
  Joel Lamon> ;Clinical Chemistry. 1972 Dec 1
• 8 citations
  Hypercalcemia and tuberculosis.
  Om P. Sharma, Joel Lamon, David Winsor> ;JAMA. 1972 Oct 30
• Enzymes in the hepatic porphyrias.
  Joel Lamon> ;Lancet. 1972 Aug 19
• Life-threatening, antiglobulin test-negative, acute autoimmune hemolytic anemia due to a non-complement-activating IgG1 kappa cold antibody with Pra specificity.
  Curtis, B. R., Lamon, J., Roelcke, D., Chaplin, H.> ;Transfusion. 1990 Nov 01
• Leadership 99. Interview by Terese Hudson.
  Butler, P., Dalton, J., Hawthorne, D., Lintjer, G., McCutcheon, S., Umbdenstock, R., Fernandez, R., Kaplan, G., Lamon, J., Ryan-Mitlyng, T., Sacks, L., Hawthorne, D., ...> ;Hosp Health Netw. 1999 Nov
• I didn't have this in mind when I went to medical school.
  Lamon, J. M.> ;Med Group Manage J. 1997 Mar 01
• Effects of altered porphyrin synthesis on brain neurochemistry.
  Silbergeld, E. K., Lamon, J. M.> ;Neurobehav Toxicol Teratol. 1982 Nov 01
• Bone cysts in mucopolysaccharidosis I S (Scheie syndrome).
  Lamon, J. M., Trojak, J. E., Abbott, M. A.> ;Johns Hopkins Med J. 1980 Feb
• Clinical aspects of porphyrin measurement, other than lead poisoning.
  Lamon, J. M.> ;Clin Chem. 1977 Feb
• Genetic risk for exposure related illness.
  Guidotti, T. L., Lamon, J. M.> ;J Occup Med. 1979 Jan
• Join now to see all